Roth David
Related Filers (3)
- Syros Pharmaceuticals, Inc. (18)
- INFINITY PHARMACEUTICALS, INC. (2)
- Allarity Therapeutics, Inc. (1)
- Show More ...
Other (3)
144
Tuesday, 12/12/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 12/6/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/31/2023
Filing for proposed sale of securities under Rule 144
Ownership (18)
4
Thursday, 12/14/2023
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/8/2023
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 11/2/2023
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/2/2023
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/4/2023
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/21/2023
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/11/2022
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 7/11/2022
Allarity Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 4/4/2022
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/17/2022
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/19/2021
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/14/2020
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/14/2019
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/21/2018
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/13/2017
Syros Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/29/2016
Syros Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 1/16/2015
INFINITY PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
3
Friday, 2/7/2014
INFINITY PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities